Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder
Key facts
- Who runs it
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 9 Dec 2025
- Expected to end
- 1 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Active Intermittent Theta-Burst Stimulation (iTBS)
- Sham Intermittent Theta-Burst Stimulation (iTBS)
- Record updated
- 12 March 2026
Who can take part
- Age
- 16 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 16 and 70 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to investigate the therapeutic effects of intermittent theta burst stimulation on social anxiety disorder and to track physiological changes in the brain using electroencephalography (EEG). Eligible SAD participants, after voluntarily signing an informed consent form, will first complete basic information collection, baseline questionnaire completion, and a pre-treatment EEG data collection session lasting approximately 30 minutes (including resting-state and task-state recordings). Subsequently, participants will be randomly assigned to one of three groups (left iTBS group, right iTBS group, or sham stimulation group) to receive intensive treatment for one week (4 sessions daily for 5 consecutive days, totaling 20 sessions). Immediately following the intervention, the research team will conduct post-treatment EEG data collection and gather questionnaire assessments. Participants will also undergo follow-up visits at weeks 2, 4, 6, and 8 post-treatment to complete questionnaires and report any adverse events. All study procedures are strictly and safely conducted by trained professionals. Participation is entirely voluntary, and participants may withdraw unconditionally at any time during the study.
The 3 groups in the trial
- Left PFC-iTBSTreatment being tested
Participants will receive active intermittent theta-burst stimulation (iTBS) targeting the left prefrontal cortex.
Treatment: Active Intermittent Theta-Burst Stimulation (iTBS)
- Right PFC-iTBSTreatment being tested
Participants will receive active intermittent theta-burst stimulation (iTBS) targeting the right prefrontal cortex.
Treatment: Active Intermittent Theta-Burst Stimulation (iTBS)
- Sham iTBSSham treatment, for comparison
Participants will receive sham intermittent theta-burst stimulation (iTBS) targeting the prefrontal cortex.
Treatment: Sham Intermittent Theta-Burst Stimulation (iTBS)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intermittent Theta-Burst Stimulation Targeting the Prefrontal Cortex for Social Anxiety Disorder: A Randomized, Parallel-Group Comparative Study
- Criteria questions
- Built from NCT07466277, who can take part
- Record updated
- 12 March 2026